MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Cordis Corporation
Taking on Complex SFA Disease
Esteemed vascular surgeon Peter Goverde discusses how interventionists should approach increasingly difficult clinical presentations.
With Peter Goverde, MD
Sponsored by iVascular
The New-Generation iCover BX Covered Stent to Treat Complex Iliac Artery Disease
By Peter Goverde, MD
The S.M.A.R.T.® Flex Vascular Stent System Solution
Technical considerations and clinical results in treating extensive femoropopliteal occlusive disease.
By Peter Goverde, MD; Kim Taeymans, MD; and Katrien Lauwers, MD
iVascular's Angiolite BTK Sirolimus-Eluting Stent Launched in Europe
July 18, 2017—iVascular announced the European launch of its Angiolite BTK sirolimus-eluting stent.
MAGNIFICENT Trial Begins in Europe for Cardionovum's Legflow DCB to Treat SFA Disease
April 13, 2016—Cardionovum GmbH recently announced the enrollment of the first patient in the multicenter, randomized, controlled MAGNIFICENT clinical trial comparing the efficacy of the company’s Legflow drug-coated balloon (DCB) with conventional percutaneous transluminal angioplasty (PTA) in de novo or recurrent lesions in the superficial femoral artery (SFA) or popliteal segment.
Cordis Launches Saber PTA Dilatation Catheter
July 1, 2014—Cordis Corporation announced the launch of its Saber percutaneous transluminal angioplasty (PTA) dilatation catheter for the treatment of patients with peripheral arterial disease.
Bentley's BeGraft Aortic Stent Graft System Launched in Europe
December 6, 2016—Bentley announced that it has launched its BeGraft aortic stent graft system, a balloon-expandable, large-diameter covered stent, which has received European CE Mark approval.
Innovations
A preview of today's new products.
An Interview With Michel M.P.J. Reijnen, MD, PhD
Prof. Reijnen ponders innovations and unmet clinical needs in the vascular field, both clinically in the Rijnstate Hospital and from a translational point of view; the aims of Multi-Modality Medical Imaging group at University of Twente; next steps for the CERAB technique; and more.
